Christopher R. Fenimore serves as Executive at REGENERON PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Christopher R. Fenimore has executed 154 insider transactions totaling $30.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 30, 2018 involved gifting 50 shares valued at $0.
Christopher R. Fenimore currently holds 18,300 shares of REGENERON PHARMACEUTICALS INC (REGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher R. Fenimore has been a net seller of REGN stock. They have purchased $0 and sold $30.3M worth of shares.
Christopher R. Fenimore's most recent insider trade was on Aug 30, 2018, when they sold 50 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 30, 2018 | REGN | $1.1K | Option Exercise | 50 | $21.25 | Discretionary |
| Jan 16, 2018 | REGN | $3.2K | Option Exercise | 150 | $21.25 | Discretionary |